Wacker Biotech, a CDMO, began a strategic collaboration with Boston-based RNAV8 Bio aimed at progressing the development and production of mRNA-based advanced therapies for the biopharma industry.
The success of the mRNA-based vaccines against SARS-CoV-2 merely hint at the healthcare implications of mRNA technology. More mRNA-based vaccines are in the works, as are mRNA-based therapeutics for ...
The modification of lipid nanoparticles with aromatic rings and disulfide bonds enhances mRNA vaccine delivery. Researchers at the University of Pennsylvania (PA, USA) have modified lipid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results